MedTrace Logo

Effect of Red Ginseng Extract on Changes in Indicators of Immune Function in Vietnamese Healthy Volunteers

NCT05480774 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2023-01-31

No results posted yet for this study

Summary

This is a placebo-controlled, randomized, double-blind, multiple dose study that evaluated the safety, tolerability, and changes in indicators of immune function of Korean Red Ginseng Extract in Vietnamese healthy subjects following oral administration of multiple dose of Korean Red Ginseng Extract as hard capsules or placebo to healthy adult men.

Conditions

  • Healthy

Interventions

DRUG

KRG hard capsule

Each subject was given orally 2 KRG hard capsules/day for 12 weeks

DRUG

Placebo hard capsule

Each subject was given orally 2 placebo hard capsules/day for 12 weeks

Sponsors & Collaborators

  • Kyunghee University

    collaborator OTHER

  • HK inno.N Corporation

    collaborator INDUSTRY

  • Centre of Clinical Pharmacology, Hanoi Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-06
Primary Completion
2022-12-03
Completion
2022-12-31

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05480774 on ClinicalTrials.gov